The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Extrapyramidal side-effects of antipsychotics in a randomised trial
Open accessAbstract
Background: There are claims that second-generation antipsychotics produce fewer extrapyramidal side-effects (EPS) compared with first-generation drugs. Aims: To compare the incidence of treatment-emergent EPS between second-generation antipsychotics and perphenazine in people with schizophrenia. Method: Incidence analyses integrated data from standardised rating scales and documented use of concomitant medication or treatment discontinuation for EPS events. Mixed model analyses of change in rating scales from baseline were also conducted. Results: There were no significant differences in incidence or change in rating scales for parkinsonism, dystonia, akathisia or tardive dyskinesia when comparing second-generation antipsychotics with perphenazine or comparing between second-generation antipsychotics. Secondary analyses revealed greater rates of concomitant antiparkinsonism medication among individuals on risperidone and lower rates among individuals on quetiapine, and lower rates of discontinuation because of parkinsonism among people on quetiapine and ziprasidone. There was a trend for a greater likelihood of concomitant medication for akathisia among individuals on risperidone and perphenazine. Conclusions: The incidence of treatment-emergent EPS and change in EPS ratings indicated that there are no significant differences between second-generation antipsychotics and perphenazine or between second-generation antipsychotics in people with schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1976) · Medical Entomology and Zoology · Cited by 8,899
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Self-citationA sharper Bonferroni procedure for multiple tests of significance
HOCHBERG, Y. (1988) · Biometrika · doi:10.1093/biomet/75.4.800 · Cited by 4,829
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
SIMPSON, G. M., B., M., B., G., ANGUS, J. W. S., P., F. R. C., & M., D. P. (1970) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1970.tb02066.x · Cited by 3,264
A Rating Scale for Drug-Induced Akathisia
Barnes, T. R. E. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.154.5.672 · Cited by 2,170
Categorical Data Analysis Using the SAS System
(1996) · Technometrics · doi:10.1080/00401706.1996.10484575 · Cited by 1,869
Methods in Observational Epidemiology
Kelsey, J. L. (1986) · Cited by 1,307
Methods in observational epidemiology
Leck, I. (1987) · Journal of Epidemiology and Community Health · doi:10.1136/jech.41.3.263-a · Cited by 1,278
Risperidone in the treatment of schizophrenia
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.6.825 · Cited by 1,193
Jones, P. B., Barnes, T. R. E., Davies, L., Dunn, G., Lloyd, H., Hayhurst, K. P., Murray, R. M., Markwick, A., & Lewis, S. W. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.10.1079 · Cited by 1,105
Keefe, R. S. E. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.6.633 · Cited by 1,065
Self-citationGeddes, J., Freemantle, N., Harrison, P., & Bebbington, P. (2000) · BMJ · doi:10.1136/bmj.321.7273.1371 · Cited by 1,062
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
Davis, J. M., Chen, N., & Glick, I. D. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.6.553 · Cited by 1,034
Research Diagnoses for Tardive Dyskinesia
Kane, J. M. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290040080014 · Cited by 937
Arvanitis, L. A., & Miller, B. G. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00190-x · Cited by 803
Leucht, S., Wahlbeck, K., Hamann, J., & Kissling, W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13306-5 · Cited by 725
Correll, C. U., Leucht, S., & Kane, J. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.414 · Cited by 709
Categorical Data Analysis Using The SAS1 System
(2001) · Technometrics · doi:10.1198/tech.2001.s617 · Cited by 647
Stroup, T. S., McEvoy, J. P., Swartz, M. S., Byerly, M. J., Glick, I. D., Canive, J. M., McGee, M. F., Simpson, G. M., Stevens, M. C., & Lieberman, J. A. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006986 · Cited by 636
Self-citationPotkin, S. G., Saha, A. R., Kujawa, M. J., Carson, W. H., Ali, M., Stock, E., Stringfellow, J., Ingenito, G., & Marder, S. R. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.681 · Cited by 591
The Expert Consensus Guideline Series
Karceski, S., Morrell, M., & Carpenter, D. (2001) · Epilepsy & Behavior · doi:10.1006/ebeh.2001.0283 · Cited by 396
Daniel, D. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00090-6 · Cited by 377
Posttraumatic stress disorder: a model of the longitudinal course and the role of risk factors.
Glazer, W. M. (2000) · PubMed · Cited by 340
Rosenheck, R. (2003) · JAMA · doi:10.1001/jama.290.20.2693 · Cited by 326
Self-citationKane (2003) · The Journal of Clinical Psychiatry · Cited by 323
Introduction: Methods, Commentary, and Summary
Alexopoulos, G. S., Streim, J. E., Carpenter, D. P., & Docherty, J. P. (2004) · The Journal of Clinical Psychiatry · Cited by 316
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.466 · Cited by 305
Swartz, M. S., Perkins, D. O., Stroup, T. S., Davis, S. M., Capuano, G., Rosenheck, R. A., Reimherr, F., McGee, M. F., Keefe, R. S. E., McEvoy, J. P., et al. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.3.428 · Cited by 291
Self-citationRosenheck, R. A., Leslie, D. L., Sindelar, J., Miller, E. A., Lin, H., Stroup, T. S., McEvoy, J., Davis, S. M., Keefe, R. S. E., Swartz, M., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.12.2080 · Cited by 281
Self-citationTardive Dyskinesia: Prevalence, Incidence, and Risk Factors
KANE, J. M., WOERNER, M., & LIEBERMAN, J. (1988) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198808001-00010 · Cited by 266
Self-citationKane, J. M., Leucht, S., Carpenter, D. P., & Docherty, J. P. (2003) · PubMed · Cited by 234
Integrating incidence and prevalence of tardive dyskinesia.
Kane, J. M., Woerner, M. G., Borenstein, M., Wegner, J. T., & Lieberman, J. A. (1986) · PubMed · Cited by 207
Self-citationEpidemiology of tardive dyskinesia: Is risk declining with modern antipsychotics?
Tarsy, D., & Baldessarini, R. J. (2006) · Movement Disorders · doi:10.1002/mds.20823 · Cited by 200
Prospective Study of Tardive Dyskinesia Incidence in the Elderly
Saltz, B. L. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470170090030 · Cited by 183
Self-citationStahl, S. M. (2003) · PubMed · Cited by 181
Stroup, T. S., Lieberman, J. A., McEvoy, J. P., Swartz, M. S., Davis, S. M., Capuano, G. A., Rosenheck, R. A., Keefe, R. S. E., Miller, A. L., Belz, I., et al. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.3.415 · Cited by 168
Self-citationTardive Dyskinesia: Prevalence, Incidence, and Risk Factors
Kane, J. M., Woerner, M. G., & Lieberman, J. A. (1985) · Psychopharmacology series · doi:10.1007/978-3-642-70140-5_9 · Cited by 161
Self-citationJeste, D. V., Okamoto, A., Napolitano, J., Kane, J. M., & Martinez, R. A. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.7.1150 · Cited by 161
Miller, D. D., McEvoy, J. P., Davis, S. M., Caroff, S. N., Saltz, B. L., Chakos, M. H., Swartz, M. S., Keefe, R. S. E., Rosenheck, R. A., Stroup, T. S., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.034 · Cited by 158
Self-citationGlazer, W. M., Morgenstern, H., & Doucette, J. T. (1993) · PubMed · Cited by 145
Incidence and Correlates of Tardive Dyskinesia in First Episode of Schizophrenia
Chakos, M., Alvir, J. M., Woerner, M. G., Koreen, A., Geisler, S., Mayerhoff, D., Sobel, S., Kane, J. M., Borenstein, M., & Lieberman, J. A. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830040049009 · Cited by 140
Self-citationPrevalence of spontaneous dyskinesia in schizophrenia.
Fenton, W. S. (2000) · PubMed · Cited by 128
Спивак, Б., Mester, R., Abesgaus, J., et al. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0706 · Cited by 125
Incidence of tardive dyskinesia: five-year data from a prospective study.
Kane, J. M., Woerner, M. G., Weinhold, P., Wegner, J. T., Kinon, B. J., & Borenstein, M. (1984) · PubMed · Cited by 111
Dolder, C. R., & Jeste, D. V. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00170-7 · Cited by 102
Haro, J. M., & Salvador‐Carulla, L. (2006) · CNS Drugs · doi:10.2165/00023210-200620040-00003 · Cited by 98
Measuring outcome priorities and preferences in people with schizophrenia
Rosenheck, R. A., Stroup, T. S., Keefe, R. S. E., McEvoy, J. M., Swartz, M. S., Perkins, D. O., Hsiao, J., Shumway, M., & Lieberman, J. A. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.187.6.529 · Cited by 81
Self-citationMedical Complications of New Antipsychotic Drugs
Umbricht, D., & Kane, J. M. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.3.475 · Cited by 80
A five year follow-up study of tardive dyskinesia.
Chouinard, G., Annable, L., Mercier, P., & Ross‐Chouinard, A. (1986) · PubMed · Cited by 69
Double-Blind Carbidopa/Levodopa and Placebo Study in Tardive Dyskinesia
Simpson, G. M., YADALAM, K. G., & STEPHANOS, M. J. (1988) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198808001-00009 · Cited by 59
Hugenholtz, G. W. K., Heerdink, E. R., Stolker, J. J., Meijer, W. E. E., Egberts, T. C. G., & Nolen, W. A. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0606 · Cited by 59
Kinon, B. J., Jeste, D. V., Kollack‐Walker, S., Stauffer, V. L., & Liu‐Seifert, H. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.016 · Cited by 56
Eberhard, J., Lindström, E., & Levander, S. E. (2005) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000182120.51672.7d · Cited by 41
Prevention and Management of Tardive Dyskinesia
Crane, G. E. (1972) · American Journal of Psychiatry · doi:10.1176/ajp.129.4.466 · Cited by 39
Incidence and Severity of Tardive Dyskinesia Increase With Age
Johnson, G. F. S. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290040080012 · Cited by 39
Gourzis, P., Polychronopoulos, P., Papapetropoulos, S., Assimakopoulos, K., Argyriou, A. A., & Beratis, S. (2005) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000174933.89758.c9 · Cited by 36
Gharabawi, G. M., Bossie, C. A., & Zhu, Y. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.5.938a · Cited by 18
Lee, C., Wu, K.-H., Habil, H., Dyachkova, Y., & Lee, P. (2006) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2006.01820.x · Cited by 17
Dr. Rosenheck and Colleagues Reply
Rosenheck, R. A., Stroup, T. S., Swartz, M. S., McEvoy, J. P., Thomas, S., Keefe, R. S. E., Hsiao, J., & Lieberman, J. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.4.678a · Cited by 7
Self-citation
Cited by
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
Buchanan, R. W., Kreyenbuhl, J., Kelly, D. L., Noel, J. M., Boggs, D. L., Fischer, B. A., Himelhoch, S., Fang, B., Peterson, E., Aquino, P. R., et al. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp116 · Cited by 907
Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Thibaut, F., Möller, H.-J., & the Wfsbp Task Force on Treatment Guidelines for Schizophrenia (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.696143 · Cited by 637
Self-citationBarnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Update on Typical and Atypical Antipsychotic Drugs
Meltzer, H. Y. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-050911-161504 · Cited by 433
Catatonia: Our current understanding of its diagnosis, treatment and pathophysiology
Rasmussen, S. A., Mazurek, M. F., & Rosebush, P. I. (2016) · World Journal of Psychiatry · doi:10.5498/wjp.v6.i4.391 · Cited by 334
Metadata
- Authors
- Miller, D. D., Caroff, S. N., Davis, S. M., Rosenheck, R. A., McEvoy, J. P., Saltz, B. L., Riggio, S., Chakos, M. H., Swartz, M. S., Keefe, R. S. E., Stroup, T. S., Lieberman, J. A., & for the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2008-10
- Volume
- 193
- Issue
- 4
- Pages
- 279-288
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2002442062
- Cited by
- 265
- References
- 59
- FWCI
- 14.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.